Screening for Lazy Eye | NYU Langone Health
Ophthalmologists at Hassenfeld Children's Hospital at NYU Langone recommend children be screened for lazy eye.
Screening for Lipid Disorders | NYU Langone Health
NYU Langone physicians recommend that all adults be screened regularly for lipid disorders.
Screening for Liver Cancer & Liver Metastases | NYU Langone Health
Doctors at NYU Langone’s Perlmutter Cancer Center screen people who are at high risk for liver cancer and liver metastases.
Screening for Osteoporosis & Low Bone Mass | NYU Langone Health
NYU Langone doctors recommend screening for women and men who may be at risk for low bone mass and osteoporosis.
Screening for Refractive Error | NYU Langone Health
Eye doctors at NYU Langone recommend regular screening for refractive error and other eye conditions during childhood and throughout life.
Screening for Scoliosis in Children | NYU Langone Health
Experts at Hassenfeld Children’s Hospital at NYU Langone begin screening children for scoliosis, an abnormal curvature of the spine, at age 10.
Screening for Sickle Cell Disease | NYU Langone Health
Doctors at Hassenfeld Children’s Hospital of New York at NYU Langone screen newborns for sickle cell disease ensuring early treatment.
Screening for Spina Bifida in Children | NYU Langone Health
NYU Langone doctors offer a quadruple screen test, prenatal ultrasound, and amniocentesis to screen for spina bifida during pregnancy.
Screening for Tuberculosis | NYU Langone Health
NYU Langone doctors perform screening tests for people who may have been exposed to tuberculosis.
ScreenPlus: A Comprehensive Flexible Multi-disorder Newborn Screening Program
Shortly after birth, all New York babies have a routine newborn screening (NBS) test that checksfor more than 50 treatable disorders. ScreenPlus is a research study where babies are screenedfor an additional 14 rare disorders that are not currently on NY’s routine NBS panel. All of thedisorders on the ScreenPlus panel have an approved treatment or an investigational therapythat is currently being tested in a clinical trial. ScreenPlus will help us understand how well NBSworks for these disorders. For more information, please reach out to ScreenPlus@nyulangone.org.